Antleron Co-Development Architect, Filip Donvil, and ICsense CEO Bram de Muer, were interviewed by BioVox, for the MEDVIA article series, to talk about the motivations and vision behind the collaborative project and offering.
The BioDevice-CRO partnership, powered by MEDVIA, provides actors with customizable, modular bioprocess solutions. Combining the multidisciplinary expertise of Antleron, Comate, and ICsense brings a unique offering to life science organizations.
A successful demonstration of a proof-of-concept device took place at Knowledge for Growth 2023.
Full article here.
Reach out to talk about your roadmap to a custom bioprocess solution!